Evidence map›Paper›PMID 37313727›Full record

ArticleJournal of the Pediatric Infectious Diseases Society2023

Respiratory Syncytial Virus Infection Among Hospitalized Infants in Four Middle-Income Countries.

Holly M Biggs, Eric A F Simões, Ilham Abu Khader, Mark G Thompson, Aubree Gordon, Danielle R Hunt, Nicholas P DeGroote, Rachael M Porter, Silvia Bino, Basima I Marar and 22 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of the Pediatric Infectious Diseases Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 10 institutions in 6 countries.

Holly M BiggsDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Eric A F SimõesSection of Infectious Diseases, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA.
Ilham Abu KhaderThe Eastern Mediterranean Public Health Network (EMPHNET), Amman, Jordan.
Mark G ThompsonInfluenza Division, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Aubree GordonAbt Associates, Inc., Atlanta, GA, USA.ORCID 0000-0002-9352-7877
Danielle R HuntDepartment of Epidemiology & Control of Infectious Diseases, Institute of Public Health, Tirana, Albania.
Nicholas P DeGrooteDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Rachael M PorterInfluenza Division, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Silvia BinoDepartment of Epidemiology & Control of Infectious Diseases, Institute of Public Health, Tirana, Albania.
Basima I MararAl-Bashir Hospital, Amman, Jordan.
Lionel GreshSustainable Sciences Institute, Managua, Nicaragua.
Joanne de Jesus-CornejoResearch Institute for Tropical Medicine, Department of Health, Muntinlupa City, Metro Manila, Philippines.
Gayle LangleyDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Natalie J ThornburgDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0003-3523-3616
Teresa C T PeretDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Brett WhitakerDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Yange ZhangDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Lijuan WangDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Mira C PatelInfluenza Division, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Meredith McMorrowDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
William CampbellDepartment of Epidemiology & Control of Infectious Diseases, Institute of Public Health, Tirana, Albania.
Iris HasibraDepartment of Epidemiology & Control of Infectious Diseases, Institute of Public Health, Tirana, Albania.
Enkeleda DukaPediatric Department, Mother Theresa University Hospital Center, Tirana, Albania.
Mahmoud Al-GazoThe Eastern Mediterranean Public Health Network (EMPHNET), Amman, Jordan.
John KubaleDepartment of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.ORCID 0000-0001-5571-9774
Felix SanchezHospital Infantil Manuel de Jesus Rivera, Ministry of Health, Managua, Nicaragua.
Marilla G LuceroResearch Institute for Tropical Medicine, Department of Health, Muntinlupa City, Metro Manila, Philippines.
Veronica L TalloResearch Institute for Tropical Medicine, Department of Health, Muntinlupa City, Metro Manila, Philippines.
Eduardo Azziz-BaumgartnerInfluenza Division, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Artan SimakuDepartment of Epidemiology & Control of Infectious Diseases, Institute of Public Health, Tirana, Albania.
Susan I GerberDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
IRIS Network
Centers for Disease Control and Prevention · USUniversity of Medicine Tirana · ALDepartment of Health · PHEastern Mediterranean Public Health Network · JOHospital Infantil Manuel de Jesús Rivera · NIUniversity of Michigan · USColorado School of Public Health · USJordan Hospital · JOMother Teresa Hospital · ALSustainable Sciences Institute · US

Funding

CDC HHS HHSD2002013M53890BIntramural CDC HHS CC999999
6 · The paper itself

Abstract

backgroundUnderstanding respiratory syncytial virus (RSV) global epidemiology is important to inform future prevention strategies.

methodsHospitalized infants <1-year-old with acute illness were enrolled prospectively in Albania, Jordan, Nicaragua, and Philippines during respiratory seasons in 2015-2017. Medical chart review, parental interview, and post-discharge follow up were conducted. Respiratory specimens were tested using real-time RT-PCR for RSV. Infant characteristics associated with very severe illness (intensive care unit [ICU] admission or receipt of supplemental oxygen) were assessed using logistic regression to adjust for potential confounders (age, sex, study site, and preterm birth).

resultsOf 3634 enrolled hospitalized infants, 1129 (31%) tested positive for RSV. The median age of RSV-positive infants was 2.7 (IQR: 1.4-6.1) months and 665 (59%) were male. Very severe illness in 583 (52%) RSV-positive infants was associated with younger age (aOR 4.1, 95% CI: 2.6-6.5 for 0-2 compared to 9-11-months; P < .01), low weight-for-age z-score (aOR 1.9, 95% CI: 1.2-2.8; P < .01), ICU care after birth (aOR 1.6, 95% CI: 1.0-2.5; P = .048), and cesarean delivery (aOR 1.4, 95% CI: 1.0-1.8; P = .03). RSV subgroups A and B co-circulated at all sites with alternating predominance by year; subgroup was not associated with severity (aOR 1.0, 95% CI: 0.8-1.4). Nine (0.8%) RSV-positive infants died during admission or within ≤30 days of discharge, of which 7 (78%) were <6-months-old.

conclusionsRSV was associated with nearly a third of infant acute illness hospitalizations in four middle-income countries during the respiratory season, where, in addition to young age, factors including low weight-for-age might be important predictors of severity. RSV prevention strategies targeting young infants could substantially reduce RSV-associated hospitalizations in middle-income countries.

Indexed as

Premature BirthRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsAcute DiseaseAftercareDeveloping CountriesFemaleHospitalizationHumansInfantInfant, NewbornMalePatient DischargeAlbaniabronchiolitisglobal healthinfantJordanNicaraguaPediatricPhilippinespneumoniaRespiratory syncytial virus

Identifiers

PMID37313727
PMCPMC11268525
OpenAlexW4380576967

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.